CD4 + and CD8 + T Cells Can Act Separately in Tumour Rejection after Immunization with Murine Pneumotropic Virus Chimeric Her2/ neu Virus-Like Particles

Kalle Andreasson, Mathilda Eriksson, Karin Tegerstedt et al. · 2010

Read CD4 + and CD8 + T Cells Can Act Separately in Tumour Rejection after Immunization with Murine Pneumotropic Virus Chimeric Her2/ neu Virus-Like Particles by Kalle Andreasson, Mathilda Eriksson, Karin Tegerstedt et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011580.txt.

Description

Kalle Andreasson and colleagues reported this mouse cancer vaccine study in PLOS ONE in 2010. Their vaccine used harmless virus-like particles carrying Her2/neu, a protein found on some tumours. Given ahead of time it blocked tumour growth, and it could also treat tumours when paired with an added booster.

The team asked which immune cells did the work. They found that CD4 helper cells and CD8 killer cells could each reject tumours on their own, without needing the other type present. That independence matters for vaccine design, since a useful vaccine may not need to trigger both arms at once.

Catalog record

CREATORKalle Andreasson, Mathilda Eriksson, Karin Tegerstedt et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011580

Browse the full library · About the Tower of Babel